Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genzyme
Pharma
Appeals court revives litigation centered on Sanofi's Fabrazyme
Genzyme was accused of causing injuries after contaminated doses of its Fabry disease med led to a shortage, during which the company rationed doses.
Zoey Becker
Feb 20, 2024 5:09pm
Europe endorses two Sanofi enzyme replacement therapies
Jun 28, 2022 11:21am
Sanofi's story gets a fresh chapter with 'eureka!' undertones
Feb 7, 2022 8:45am
Sanofi's late-onset Pompe prospect has scooped its green light
Aug 6, 2021 2:39pm
Ex-Genzyme CFO takes up exec chair role at delivery specialist
Jul 27, 2021 6:24am
ReForm taps ex-Genzyme exec to lead subq delivery strategy
Mar 2, 2021 7:40am